Publications by authors named "Udit Chaube"

Claim this Profile
A
Advancements in breast cancer therapy: Integrating AI tools for drug discovery and clinical trials.
Vinita Pandey, Priyanka Verma, Gopal Natesan, Udit Chaube

Comput Biol Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Morpholine-Substituted Tetrahydroquinoline Derivatives as Potential mTOR Inhibitors: Synthesis, Computational Insights, and Cellular Analysis.
Rajdeep Dey, Suman Shaw, Ruchi Yadav, Bhumika D Patel, Hardik G Bhatt, Udit Chaube

Cancers (Basel)· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ellagic acid improves the symptoms of early-onset Alzheimer's disease: Behavioral and physiological correlates.
Abhishek B Jha, Udit J Chaube, Ashish B Jha

Heliyon· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A hypothesis on designing strategy of effective RdRp inhibitors for the treatment of SARS-CoV-2.
Udit Chaube, Bhumika D Patel, Hardik G Bhatt

3 Biotech· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tetrahydroquinoline: an efficient scaffold as mTOR inhibitor for the treatment of lung cancer.
Udit Chaube, Rajdeep Dey, Suman Shaw, Bhumika D Patel, Hardik G Bhatt

Future Med Chem· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and development of Tetrahydro-Quinoline derivatives as dual mTOR-C1/C2 inhibitors for the treatment of lung cancer.
Udit J Chaube, Rakesh Rawal, Abhishek B Jha, Bhavesh Variya, Hardik G Bhatt

Bioorg Chem· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CoMFA, CoMSIA, Topomer CoMFA, HQSAR, molecular docking and molecular dynamics simulations study of triazine morpholino derivatives as mTOR inhibitors for the treatment of breast cancer.
Dhara M Chhatbar, Udit J Chaube, Vivek K Vyas, Hardik G Bhatt

Comput Biol Chem· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beneficial Effect of Silymarin in Pressure Overload Induced Experimental Cardiac Hypertrophy.
Basant Sharma, Udit Chaube, Bhoomika M Patel

Cardiovasc Toxicol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
3
3D-QSAR, molecular dynamics simulations, and molecular docking studies on pyridoaminotropanes and tetrahydroquinazoline as mTOR inhibitors.
Udit Chaube, Hardik Bhatt

Mol Divers· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
3
3D-QSAR, molecular dynamics simulations and molecular docking studies of benzoxazepine moiety as mTOR inhibitor for the treatment of lung cancer.
Udit Chaube, Dhara Chhatbar, Hardik Bhatt

Bioorg Med Chem Lett· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis